Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Chem Biol ; 29(1): 3-4, 2022 01 20.
Artigo em Inglês | MEDLINE | ID: mdl-35063066

RESUMO

Ferroptosis is an iron-dependent form of cell death implicated in cancer and neurodegenerative diseases. In this issue of Cell Chemical Biology, Shao et al. (2022) and Wang et al. (2022) describe imaging techniques to monitor ferrous iron levels and iron-dependent lipid peroxidation, two key determinants of ferroptosis sensitivity.


Assuntos
Ferroptose , Doenças Neurodegenerativas , Morte Celular , Humanos , Ferro , Peroxidação de Lipídeos
2.
Cell Commun Signal ; 18(1): 154, 2020 09 18.
Artigo em Inglês | MEDLINE | ID: mdl-32948192

RESUMO

BACKGROUND: Hormone receptor positive (HR+) breast cancer (BCa) is the most frequently diagnosed subtype. Acquired and intrinsic resistance to conventional endocrine therapy (ET) commonly occurs and prompts incurable metastatic disease. Hence, ET-resistant (ET-R) HR+ BCa presents a therapeutic challenge. Previous studies show elevated androgen receptor (AR) that supports resistance to ET tamoxifen and correlates with HR+ BCa metastasis. Yet surprisingly, studies with AR-blocker enzalutamide (Enz) in ET-R HR+ BCa present conflicting results. We now report that a constitutively active, unique from canonical Enz-targeted, AR accumulates in endocrine resistant HR+ BCa cells. METHODS: AR protein profiles in acquired and intrinsic ET-R HR + -BCa were defined with cell-free modification tests, in-house in-vivo SUMOylation assays, and PLA imaging. Genomic activity of native AR and modified-AR mimetic was tested with reporter assays and limited transcriptome analysis. Spheroid growth and migration studies were used to evaluate inhibitory actions of Enz and combinatorial therapy. RESULTS: Sustained higher molecular weight SUMO-modified AR (SUMO-AR) persists in acquired and intrinsic ET-R BCa cell lines. Concurrently, SUMO isoforms and global SUMO-modified proteome also accumulates in the same cell lines. We identified AR as a novel substrate for the SUMO-E3 ligase HSPB1/Hsp27. Independent of ligand, SUMO-AR is resilient to ubiquitin-mediated proteasomal degradation, enriched in the nucleus, readily chromatin-bound, and transcriptionally active. Constitutive SUMO-AR initiates a gene-expression profile that favors epithelial-mesenchymal transition. Enz combined with a SUMO inhibitor attenuates migration and metastatic phenotype of ET-R HR+ BCa. CONCLUSION: Targeting both unmodified and SUMO-modified AR prevents the metastatic progression of HR+ BCa with ET-R. Video abstract.


Assuntos
Antineoplásicos Hormonais/farmacologia , Neoplasias da Mama/metabolismo , Receptores Androgênicos/metabolismo , Proteína SUMO-1/metabolismo , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/patologia , Movimento Celular/efeitos dos fármacos , Resistencia a Medicamentos Antineoplásicos , Feminino , Humanos , Células MCF-7 , Invasividade Neoplásica/patologia , Proteólise/efeitos dos fármacos , Sumoilação/efeitos dos fármacos
3.
Oncotarget ; 8(11): 17651-17664, 2017 Mar 14.
Artigo em Inglês | MEDLINE | ID: mdl-27852060

RESUMO

SUMO protease SENP1 is elevated in multiple carcinomas including prostate cancer (PCa). SENP1 exhibits carcinogenic properties; it promotes androgen receptor-dependent and -independent cell proliferation, stabilizes HIF1α, increases VEGF, and supports angiogenesis. However, mice expressing an androgen-responsive promoter driven SENP1-transgene (SENP1-Tg) develop high-grade prostatic intraepithelial neoplasia, but not carcinoma. We now show that tumor suppressive PTEN signaling is induced in SENP1-Tg to enhance prostate epithelial cell apoptosis. SENP1 blocks SUMO1-dependent ubiquitylation and degradation of PTEN. In the absence of SENP1, SUMO1-modified PTEN is sequestered in the cytosol, where binding to ubiquitin-E3 ligase WWP2 occurs. Concurrently, WWP2 is also SUMOylated, which potentiates its interaction with PTEN. Thus, SENP1 directs ubiquitin-E3-substrate association to control PTEN stability. PTEN serves as a barrier for SENP1-mediated prostate carcinogenesis as SENP1-Tg mice develop invasive carcinomas only after PTEN reduction. Hence, SENP1 modulates multiple facets of carcinogenesis and may serve as a target specifically for aggressive PTEN-deficient PCa.


Assuntos
Transformação Celular Neoplásica/patologia , Cisteína Endopeptidases/metabolismo , Endopeptidases/metabolismo , PTEN Fosfo-Hidrolase/metabolismo , Neoplasias da Próstata/patologia , Animais , Apoptose , Transformação Celular Neoplásica/metabolismo , Modelos Animais de Doenças , Regulação Neoplásica da Expressão Gênica/fisiologia , Humanos , Immunoblotting , Imuno-Histoquímica , Imunoprecipitação , Masculino , Camundongos , Camundongos Transgênicos , Neoplasias da Próstata/metabolismo , Estabilidade Proteica
4.
Nat Prod Res ; 30(2): 228-31, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-25981986

RESUMO

To identify the structures of flavonoid glycosides in bee pollen collected from rapeseed plants (Brassica napus L.), we utilised an approach that combined liquid chromatography-diode array detector-electrospray ionization-mass spectrometry (LC-DAD-ESI-MS) and nuclear magnetic resonance (NMR) technology with a step-wise separation strategy. We identified four constituents of high purity in rape bee pollen samples: (1) quercetin-3-O-ß-D-glucosyl-(2→l)-ß-glucoside, (2) kaempferol-3, 4'-di-O-ß-D-glucoside, (3) 5, 7, 4'-trihydroxy-3'-methoxyflavone-3-O-ß-D-sophoroside and (4) kaempferol-3-O-ß-D-glucosyl-(2→l)-ß-D-glucoside. This study will also provide useful reference standards for qualification and quantification of four flavonoid glycosides in natural products.


Assuntos
Brassica napus/química , Glicosídeos/química , Pólen/química , Animais , Abelhas , Linhagem Celular/efeitos dos fármacos , Fracionamento Químico , Cromatografia Líquida , Avaliação Pré-Clínica de Medicamentos/métodos , Flavonoides/química , Glicosídeos/isolamento & purificação , Glicosídeos/farmacologia , Concentração Inibidora 50 , Espectroscopia de Ressonância Magnética/métodos , Substâncias Protetoras/química , Substâncias Protetoras/farmacologia , Espectrometria de Massas por Ionização por Electrospray/métodos
5.
Cell Rep ; 12(5): 734-42, 2015 Aug 04.
Artigo em Inglês | MEDLINE | ID: mdl-26212320

RESUMO

SUMOylation has been implicated in cellular stress adaptation, but its role in regulating liver kinase B1 (LKB1), a major upstream kinase of the energy sensor AMP-activated protein kinase (AMPK), is unknown. Here, we show that energy stress triggers an increase in SUMO1 modification of LKB1, despite a global reduction in both SUMO1 and SUMO2/3 conjugates. During metabolic stress, SUMO1 modification of LKB1 lysine 178 is essential in promoting its interaction with AMPK via a SUMO-interacting motif (SIM) essential for AMPK activation. The LKB1 K178R SUMO mutant had defective AMPK signaling and mitochondrial function, inducing death in energy-deprived cells. These results provide additional insight into how LKB1-AMPK signaling is regulated during energy stress, and they highlight the critical role of SUMOylation in maintaining the cell's energy equilibrium.


Assuntos
Proteínas Quinases Ativadas por AMP/metabolismo , Metabolismo Energético , Proteínas Serina-Treonina Quinases/metabolismo , Proteína SUMO-1/metabolismo , Estresse Fisiológico , Sumoilação , Quinases Proteína-Quinases Ativadas por AMP , Proteínas Quinases Ativadas por AMP/genética , Substituição de Aminoácidos , Animais , Células HEK293 , Células HeLa , Humanos , Camundongos , Camundongos Knockout , Mutação de Sentido Incorreto , Proteínas Serina-Treonina Quinases/genética , Proteína SUMO-1/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...